HIV and hepatitis B coinfection in Southern Africa: A review for general practitioners

Theunis Kotzee, Paul Pronyk, Efthyia Vardas, Adele Heyer, Neil A. Martinson

Research output: Contribution to journalArticle

Abstract

Sub-Saharan Africa is facing serious HIV and hepatitis B epidemics, with coinfection becoming a major public health problem. In addition, the prevention and treatment of concurrent illnesses such as hepatitis B in HIV-infected people is becoming increasingly important as their life expectancy lengthens due to treatment with highly active antiretroviral therapy (HAART). Despite the important epidemiological burden and clinical consequences of coinfection, there is a paucity of research to inform practice that derives from studies conducted in highly endemic regions. This article reviews the current status and limitations of knowledge on coinfection with the hepatitis B virus (HBV) and HIV. It will examine the basic epidemiology of coinfection; the implications for disease progression of each condition; the therapeutic implications including drug toxicities; and current evidence and guidelines for the use of vaccine-based prevention strategies. In addition the article highlights critical areas for future research on coinfection in sub-Saharan Africa.

Original languageEnglish (US)
Pages (from-to)38-44
Number of pages7
JournalSouthern African Journal of HIV Medicine
Issue number23
StatePublished - Jun 2006
Externally publishedYes

Fingerprint

Southern Africa
Hepatitis B
Coinfection
General Practitioners
HIV
Africa South of the Sahara
Highly Active Antiretroviral Therapy
Life Expectancy
Drug-Related Side Effects and Adverse Reactions
Hepatitis B virus
Disease Progression
Epidemiology
Therapeutics
Vaccines
Public Health
Guidelines
Research

ASJC Scopus subject areas

  • Virology
  • Public Health, Environmental and Occupational Health

Cite this

Kotzee, T., Pronyk, P., Vardas, E., Heyer, A., & Martinson, N. A. (2006). HIV and hepatitis B coinfection in Southern Africa: A review for general practitioners. Southern African Journal of HIV Medicine, (23), 38-44.

HIV and hepatitis B coinfection in Southern Africa : A review for general practitioners. / Kotzee, Theunis; Pronyk, Paul; Vardas, Efthyia; Heyer, Adele; Martinson, Neil A.

In: Southern African Journal of HIV Medicine, No. 23, 06.2006, p. 38-44.

Research output: Contribution to journalArticle

Kotzee, T, Pronyk, P, Vardas, E, Heyer, A & Martinson, NA 2006, 'HIV and hepatitis B coinfection in Southern Africa: A review for general practitioners', Southern African Journal of HIV Medicine, no. 23, pp. 38-44.
Kotzee, Theunis ; Pronyk, Paul ; Vardas, Efthyia ; Heyer, Adele ; Martinson, Neil A. / HIV and hepatitis B coinfection in Southern Africa : A review for general practitioners. In: Southern African Journal of HIV Medicine. 2006 ; No. 23. pp. 38-44.
@article{1e113980030c44aca382dd5e755bb8cd,
title = "HIV and hepatitis B coinfection in Southern Africa: A review for general practitioners",
abstract = "Sub-Saharan Africa is facing serious HIV and hepatitis B epidemics, with coinfection becoming a major public health problem. In addition, the prevention and treatment of concurrent illnesses such as hepatitis B in HIV-infected people is becoming increasingly important as their life expectancy lengthens due to treatment with highly active antiretroviral therapy (HAART). Despite the important epidemiological burden and clinical consequences of coinfection, there is a paucity of research to inform practice that derives from studies conducted in highly endemic regions. This article reviews the current status and limitations of knowledge on coinfection with the hepatitis B virus (HBV) and HIV. It will examine the basic epidemiology of coinfection; the implications for disease progression of each condition; the therapeutic implications including drug toxicities; and current evidence and guidelines for the use of vaccine-based prevention strategies. In addition the article highlights critical areas for future research on coinfection in sub-Saharan Africa.",
author = "Theunis Kotzee and Paul Pronyk and Efthyia Vardas and Adele Heyer and Martinson, {Neil A.}",
year = "2006",
month = "6",
language = "English (US)",
pages = "38--44",
journal = "Southern African Journal of HIV Medicine",
issn = "1608-9693",
publisher = "South African Medical Association",
number = "23",

}

TY - JOUR

T1 - HIV and hepatitis B coinfection in Southern Africa

T2 - A review for general practitioners

AU - Kotzee, Theunis

AU - Pronyk, Paul

AU - Vardas, Efthyia

AU - Heyer, Adele

AU - Martinson, Neil A.

PY - 2006/6

Y1 - 2006/6

N2 - Sub-Saharan Africa is facing serious HIV and hepatitis B epidemics, with coinfection becoming a major public health problem. In addition, the prevention and treatment of concurrent illnesses such as hepatitis B in HIV-infected people is becoming increasingly important as their life expectancy lengthens due to treatment with highly active antiretroviral therapy (HAART). Despite the important epidemiological burden and clinical consequences of coinfection, there is a paucity of research to inform practice that derives from studies conducted in highly endemic regions. This article reviews the current status and limitations of knowledge on coinfection with the hepatitis B virus (HBV) and HIV. It will examine the basic epidemiology of coinfection; the implications for disease progression of each condition; the therapeutic implications including drug toxicities; and current evidence and guidelines for the use of vaccine-based prevention strategies. In addition the article highlights critical areas for future research on coinfection in sub-Saharan Africa.

AB - Sub-Saharan Africa is facing serious HIV and hepatitis B epidemics, with coinfection becoming a major public health problem. In addition, the prevention and treatment of concurrent illnesses such as hepatitis B in HIV-infected people is becoming increasingly important as their life expectancy lengthens due to treatment with highly active antiretroviral therapy (HAART). Despite the important epidemiological burden and clinical consequences of coinfection, there is a paucity of research to inform practice that derives from studies conducted in highly endemic regions. This article reviews the current status and limitations of knowledge on coinfection with the hepatitis B virus (HBV) and HIV. It will examine the basic epidemiology of coinfection; the implications for disease progression of each condition; the therapeutic implications including drug toxicities; and current evidence and guidelines for the use of vaccine-based prevention strategies. In addition the article highlights critical areas for future research on coinfection in sub-Saharan Africa.

UR - http://www.scopus.com/inward/record.url?scp=33748369437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748369437&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33748369437

SP - 38

EP - 44

JO - Southern African Journal of HIV Medicine

JF - Southern African Journal of HIV Medicine

SN - 1608-9693

IS - 23

ER -